<0.001 EU per 1 μg of the peptide by the LAL method
For the intralesional treatment of refractory or recurring external condylomata acuminata.
Examples of Clinical Use:
Refractory or recurring external condylomata acuminata.
The product upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2'-5' oligoadenylate synthetase (2'-5' A synthetase), beta-2 microglobulin, neopterin and protein kinase R.
Mechanism of action:
Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription) which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta.
Interferon alfa-n3, also known as Alferon N, is a therapeutic protein that belongs to the class of interferons. Interferons are a group of naturally occurring proteins that play a crucial role in the immune response against viral infections, cancer, and other diseases.
Interferon alfa-n3 is a recombinant form of interferon alfa produced using biotechnology. It is designed to mimic the actions of naturally occurring interferon alphas in the body. Interferon alfa-n3 has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain indications. The main mechanism of action of interferon alfa-n3 is its ability to activate various immune system components, leading to an enhanced immune response against viral infections and cancer cells. It stimulates the production of antiviral proteins, inhibits viral replication, modulates the immune system, and plays a role in regulating cell growth and differentiation.
The use of interferon alfa-n3 has been studied in various medical conditions such as chronic hepatitis C, hairy cell leukemia, condylomata acuminata (genital warts), and some types of human papillomavirus (HPV) infections. It may also have potential applications in other diseases, including certain types of cancers and autoimmune disorders.Interferon alfa-n3 is administered via injection, either subcutaneously or intramuscularly. Dosage and treatment duration may vary depending on the specific condition being treated and individual patient factors. Common side effects of interferon alfa-n3 treatment include flu-like symptoms, fatigue, fever, injection site reactions, and changes in blood cell counts.
2. Composition and function of Interferon alfa-n3
Interferon alfa-n3 is a recombinant form of interferon alpha, which is a naturally occurring protein in the body. It is produced using genetic engineering techniques by inserting the gene for interferon alpha into a suitable host, such as bacteria or mammalian cells. The specific composition of interferon alfa-n3 can vary depending on the production method and formulation. However, in general, interferon alfa-n3 is a protein molecule that consists of a chain of amino acids. The amino acid sequence is designed to closely mimic the natural interferon alpha produced by the human body. Interferon alfa-n3 typically contains around 165 to 166 amino acids, although minor variations can occur.
The recombinant production of interferon alfa-n3 allows for the production of large quantities of the protein, ensuring a stable and consistent supply. It is typically available in the form of a solution or lyophilized powder for injection. It is important to note that the specific formulation and details regarding the excipients or other ingredients used in the manufacturing process may vary depending on the manufacturer and specific product. Therefore, it is always necessary to refer to the specific product information and labeling for accurate and detailed composition information.
Interferon alfa-n3 has several functions and biological effects in the body, primarily related to its immunomodulatory and antiviral properties. Some of its key functions include:
Antiviral Activity: Interferon alfa-n3 has potent antiviral activity against a wide range of viruses, including hepatitis B and C viruses, human papillomavirus (HPV), and human immunodeficiency virus (HIV). It inhibits viral replication by inducing a cellular antiviral state, interfering with viral protein synthesis, and enhancing the immune response against the virus.
Immunomodulatory Effects: Interferon alfa-n3 plays a crucial role in modulating the immune response. It enhances the activity of natural killer cells, which are responsible for detecting and destroying virus-infected cells. It also stimulates the production of other immune cells, such as T cells and B cells, which help eliminate viruses and regulate the immune response.
Antiproliferative Effects: Interferon alfa-n3 has antiproliferative properties, meaning it can inhibit the replication and growth of certain types of cancer cells. It does so by regulating cell cycle progression, inducing apoptosis (programmed cell death), and inhibiting angiogenesis (formation of new blood vessels) in tumors.
Anti-inflammatory Effects: Interferon alfa-n3 can reduce inflammation by suppressing the production of pro-inflammatory cytokines and stimulating the production of anti-inflammatory molecules. This can be beneficial in autoimmune diseases and other conditions characterized by excessive inflammation.
3. Clinical application of Interferon alfa-n3
Interferon alfa-n3 has several clinical applications due to its immunomodulatory and antiviral properties. Here are some of its main clinical applications:
Chronic Hepatitis B and C: Interferon alfa-n3 is used in the treatment of chronic hepatitis B and C infections. It helps to reduce the replication of the virus and improve liver function. It is often used in combination with other antiviral medications.
Kaposi's Sarcoma: Interferon alfa-n3 can be used in the treatment of Kaposi's sarcoma, a type of cancer that affects the blood vessels and skin. It helps to slow the growth of cancer cells and reduce the size of tumors.
Hairy Cell Leukemia: Interferon alfa-n3 can be used as a treatment for hairy cell leukemia, a rare type of cancer that affects the bone marrow and white blood cells. It helps to suppress the growth of cancer cells and improve blood cell production.
Genital Warts: Interferon alfa-n3 can be used topically or injected into the warts to treat genital warts caused by human papillomavirus (HPV). It helps to stimulate the immune system to attack and eradicate the warts.
Melanoma: Interferon alfa-n3 may be used as an adjuvant therapy for high-risk melanoma, a type of skin cancer. It can help to improve the body's immune response against the cancer cells.
Multiple Sclerosis: Interferon alfa-n3 has also been used in the treatment of multiple sclerosis (MS) to reduce the frequency and severity of relapses. It works by modulating the immune response and reducing inflammation in the central nervous system.
It is important to note that the specific use of interferon alfa-n3 may vary depending on the country, healthcare provider, and patient's individual condition. Additionally, the treatment may have various side effects and should be administered under the supervision of a healthcare professional.
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products
without prior written approval from Creative BioMart.
For more information on how our products could help advance your project, please contact us.